161 related articles for article (PubMed ID: 2868480)
1. Effects of mianserin in neuroleptic-induced parkinsonism.
Korsgaard S; Friis T
Psychopharmacology (Berl); 1986; 88(1):109-11. PubMed ID: 2868480
[TBL] [Abstract][Full Text] [Related]
2. Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics.
Prosser ES; Csernansky JG; Kaplan J; Thiemann S; Becker TJ; Hollister LE
J Nerv Ment Dis; 1987 Feb; 175(2):100-5. PubMed ID: 2879880
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of L-dopa and procyclidine on neuroleptic-induced extrapyramidal and schizophrenic symptoms.
Chouinard G; Annable L; Mercier P; Turnier L
Psychopharmacol Bull; 1987; 23(1):221-6. PubMed ID: 2885889
[No Abstract] [Full Text] [Related]
4. Vitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled study.
Miodownik C; Lerner V; Statsenko N; Dwolatzky T; Nemets B; Berzak E; Bergman J
Clin Neuropharmacol; 2006; 29(2):68-72. PubMed ID: 16614537
[TBL] [Abstract][Full Text] [Related]
5. 5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo.
Bersani G; Grispini A; Marini S; Pasini A; Valducci M; Ciani N
Clin Neuropharmacol; 1990 Dec; 13(6):500-6. PubMed ID: 2125857
[TBL] [Abstract][Full Text] [Related]
6. Ethopropazine and benztropine in neuroleptic-induced parkinsonism.
Chouinard G; Annable L; Ross-Chouinard A; Kropsky ML
J Clin Psychiatry; 1979 Mar; 40(3):147-52. PubMed ID: 33969
[TBL] [Abstract][Full Text] [Related]
7. Fluperlapine in tardive dyskinesia and parkinsonism.
Korsgaard S; Noring U; Gerlach J
Psychopharmacology (Berl); 1984; 84(1):76-9. PubMed ID: 6149595
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study.
Avorn J; Bohn RL; Mogun H; Gurwitz JH; Monane M; Everitt D; Walker A
Am J Med; 1995 Jul; 99(1):48-54. PubMed ID: 7598142
[TBL] [Abstract][Full Text] [Related]
9. Serotonergic agents in the treatment of acute neuroleptic-induced akathisia: open-label study of buspirone and mianserin.
Poyurovsky M; Weizman A
Int Clin Psychopharmacol; 1997 Sep; 12(5):263-8. PubMed ID: 9466160
[TBL] [Abstract][Full Text] [Related]
10. A double-blind group comparative trial of mianserin and diazepam in depressed outpatients.
Hamouz W; Pinder RM; Stulemeijer SM
Pharmakopsychiatr Neuropsychopharmakol; 1980 Mar; 13(2):79-83. PubMed ID: 7433519
[TBL] [Abstract][Full Text] [Related]
11. A double blind comparative study of mianserin and a fixed combination of amitriptyline plus chlordiazepoxide.
Dimitriou EC; Logothetis JA; Paschalidou M
Adv Biochem Psychopharmacol; 1982; 32():213-22. PubMed ID: 7046365
[TBL] [Abstract][Full Text] [Related]
12. [A double-blind comparison between mianserin and imipramine (author's transl)].
Pull CB; Pichot P; Dreyfus JF
Acta Psychiatr Belg; 1978; 78(5):827-32. PubMed ID: 375686
[TBL] [Abstract][Full Text] [Related]
13. Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin. Double-blind, placebo-controlled study.
Poyurovsky M; Shardorodsky M; Fuchs C; Schneidman M; Weizman A
Br J Psychiatry; 1999 Mar; 174():238-42. PubMed ID: 10448449
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of the effects of lofepramin and mianserin in depressed patients in a double blind trial].
Gonçalves N; Wegener G
Int Pharmacopsychiatry; 1979; 14(6):310-8. PubMed ID: 398350
[TBL] [Abstract][Full Text] [Related]
15. Clinical management of acute neuroleptic-induced extrapyramidal syndromes.
Keepers GA; Casey DE
Curr Psychiatr Ther; 1986; 23():139-57. PubMed ID: 2870879
[No Abstract] [Full Text] [Related]
16. A double-blind multicentre trial comparing mianserin with imipramine.
Pichot P; Dreyfus JF; Pull C
Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):87S-90S. PubMed ID: 341950
[TBL] [Abstract][Full Text] [Related]
17. A controlled comparative trial of mianserin and diazepam in the treatment of anxiety states in psychiatric out-patients.
Conti L; Pinder RM
J Int Med Res; 1979; 7(4):285-9. PubMed ID: 385399
[TBL] [Abstract][Full Text] [Related]
18. An experimental evaluation of the euphoric properties of antiparkinson drugs on psychotic patients.
Vågen R; Götestam KG
Acta Psychiatr Scand; 1986 Nov; 74(5):519-23. PubMed ID: 2880460
[TBL] [Abstract][Full Text] [Related]
19. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
Silver H; Geraisy N; Schwartz M
J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
[TBL] [Abstract][Full Text] [Related]
20. Bulimia nervosa: a placebo controlled double-blind therapeutic trial of mianserin.
Sabine EJ; Yonace A; Farrington AJ; Barratt KH; Wakeling A
Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):195S-202S. PubMed ID: 6337607
[No Abstract] [Full Text] [Related]
[Next] [New Search]
